Xiaman Wang

420 total citations
7 papers, 67 citations indexed

About

Xiaman Wang is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaman Wang has authored 7 papers receiving a total of 67 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Xiaman Wang's work include Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Xiaman Wang is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Xiaman Wang collaborates with scholars based in China, United States and Australia. Xiaman Wang's co-authors include Ying Shen, Peihua Zhang, Yuandong Feng, Jinsong Hu, Yue Peng, Aili He, Giulia Biancon, Yuanbin Song, Amisha Patel and Rana Gbyli and has published in prestigious journals such as Blood, Life Sciences and Leukemia.

In The Last Decade

Xiaman Wang

7 papers receiving 67 citations

Peers

Xiaman Wang

MB

HEMAT

ONCOL

CR

SURGE

Katayoon Kasaian Canada

Kathleen Stabla Germany

Narmin Ibrahimova Canada

Hannah M. Jacobs United States

Lenny Straszkowski Australia

Konstanze Doehner Germany

Aisha Jibril United Kingdom

Kalyan Nadiminti United States

Tina Giese United States

Nikolaus Jahn Germany

Katayoon Kasaian Canada

Xiaman Wang

29 ×0.7

MB

15 ×0.5

HEMAT

25 ×0.9

ONCOL

16 ×0.9

CR

5 ×0.7

SURGE

Citations per year, relative to Xiaman Wang Xiaman Wang (= 1×) peers Katayoon Kasaian

Countries citing papers authored by Xiaman Wang

Since Specialization

Citations

This map shows the geographic impact of Xiaman Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaman Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaman Wang more than expected).

Fields of papers citing papers by Xiaman Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaman Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaman Wang. The network helps show where Xiaman Wang may publish in the future.

Co-authorship network of co-authors of Xiaman Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaman Wang. A scholar is included among the top collaborators of Xiaman Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaman Wang. Xiaman Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gbyli, Rana, Yuanbin Song, Wei Liu, et al.. (2022). In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2. Leukemia. 36(5). 1313–1323. 18 indexed citations

2.

He, Xi, Yumei Li, Yongqing Li, et al.. (2022). Self-sampled specimens demonstrate comparable accuracy and consistency to clinician-sampled specimens for HPV detection among men who have sex with men in China. Sexually Transmitted Infections. 99(2). sextrans–2022. 7 indexed citations

3.

Peng, Yue, Peihua Zhang, Xiaman Wang, et al.. (2020). IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition. Life Sciences. 249. 117503–117503. 32 indexed citations

4.

Song, Yuanbin, Rana Gbyli, Liang Shan, et al.. (2020). Reconstruction of Sickle Cell Disease with Circulating Sickling Red Blood Cells in Novel Humanized Cytokines and Liver Mistrg Mice. Blood. 136(Supplement 1). 29–30. 3 indexed citations

5.

Gbyli, Rana, Yuanbin Song, Wei Liu, et al.. (2019). PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors. Blood. 134(Supplement_1). 4222–4222. 3 indexed citations

6.

Biancon, Giulia, Poorval Joshi, Yimeng Gao, et al.. (2019). U2AF1 Driver Mutations in Hematopoietic Disorders Alter but Do Not Abrogate RNA Binding and Enlighten Structural Dependencies of the U2AF-RNA Complex. Blood. 134(Supplement_1). 1230–1230. 1 indexed citations

7.

Bai, Ju, JianLi Wang, Yun Yang, et al.. (2019). Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens. Hematology. 24(1). 387–391. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact